AbCellera Biologics
Innovator in antibody discovery for therapeutics, and immune profiling for vaccine research. Learn more
Launch date
Employees
Market cap
AUD1.2b
Enterprise valuation
AUD294m (Public information from Sep 2024)
Share price
$2.74 ABCL
Vancouver British Columbia (HQ)
Authorizing premium user...